Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2017 Oct 15;65(8):1388-1395.
doi: 10.1093/cid/cix524.

Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Effectiveness of Influenza Vaccines in Asthma: A Systematic Review and Meta-Analysis

Eleftheria Vasileiou et al. Clin Infect Dis. .

Abstract

There is uncertainty about the effectiveness of influenza vaccination in persons with asthma and its impact on asthma outcomes, which may contribute to the suboptimal vaccination rates in persons with asthma. This systematic review and meta-analysis involved searching 12 international databases for randomized controlled trials (RCTs) and high-quality quasi-experimental and epidemiological studies (1970-2016). The risk of bias was low for 3 included RCTs. The quality of 3 included observational studies was moderate. The quality of evidence was very low for all study outcomes. Pooled vaccine effectiveness in 1825 persons with asthma from 2 test-negative design case-control studies was 45% (95% confidence interval [CI], 31%-56%) for laboratory-confirmed influenza. Pooled efficacy of live vaccines in reducing influenza was 81% (95% CI, 33%- 94%). Live vaccine reduced febrile illness by 72% (95% CI, 20%-90%). Influenza vaccine prevented 59%-78% of asthma attacks leading to emergency visits and/or hospitalizations. For persons with asthma, influenza vaccination may be effective in both reducing influenza infection and asthma attacks.

Keywords: asthma; immunization; influenza; laboratory confirmed influenza; vaccination.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) diagram.
Figure 2.
Figure 2.
Risk of bias summary. Review authors’ judgments about each risk of bias item are shown for each randomized controlled trial. This rating was based on the Cochrane guideline. VE, Vaccine efficacy/effectiveness.
Figure 3.
Figure 3.
Quality assessment of the nonrandomized controlled trials and observational studies using the Effective Public Health Practice Project quality assessment tool [22].
Figure 4.
Figure 4.
Vaccine efficacy/effectiveness against influenza infection for live attenuated influenza vaccine versus no vaccine (randomized controlled trials). Abbreviations: CI, confidence interval; RR, risk ratio.
Figure 5.
Figure 5.
Vaccine efficacy/effectiveness against laboratory-confirmed (confirmed with real-time polymerase chain reaction) influenza infection for seasonal influenza vaccine versus no vaccine (test-negative design studies). Abbreviations: CI, confidence interval; OR, odds ratio.
Figure 6.
Figure 6.
Vaccine efficacy/effectiveness against febrile illness for live attenuated influenza vaccine versus no vaccine (randomized controlled trials). Abbreviations: CI, confidence interval; RR, risk ratio.

References

    1. Nair H, Brooks WA, Katz M et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011; 378:1917–30. - PubMed
    1. Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086–96. - PubMed
    1. Public Health England. Influenza: the green book. Chapter 19. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/fil.... Accessed 10 March 2015.
    1. Ritchie AI, Jackson DJ, Edwards MR, Johnston SL. Airway epithelial orchestration of innate immune function in response to virus infection: a focus on asthma. Ann Am Thorac Soc 2016; 13(suppl 1):S55–63. - PubMed
    1. Gill MA, Bajwa G, George TA et al. Counterregulation between the FεRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 2010; 184:5999–6006. - PMC - PubMed

MeSH terms

Substances